|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2003-6-26
|
|
pubmed:abstractText |
A series of boronic-chalcone derivatives were synthesized and tested for antitumor activity against human breast cancer cell lines. The results show the boronic-chalcones are more toxic to breast cancer cells compared to normal breast cells than other known chalcones.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0022-2623
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
3
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2813-5
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12825923-Antineoplastic Agents,
pubmed-meshheading:12825923-Boron Compounds,
pubmed-meshheading:12825923-Cell Division,
pubmed-meshheading:12825923-Chalcone,
pubmed-meshheading:12825923-Drug Screening Assays, Antitumor,
pubmed-meshheading:12825923-Humans,
pubmed-meshheading:12825923-Nuclear Proteins,
pubmed-meshheading:12825923-Proto-Oncogene Proteins,
pubmed-meshheading:12825923-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:12825923-Tumor Cells, Cultured
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
|
|
pubmed:affiliation |
Division of Experimental Therapeutics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
